With the formation of the Commission on Innovation and Advancement within AAPP, we have seen growth in the number of AAPP papers published in our very own Mental Health Clinician as well as other high-impact journals. The topics are tightly aligned with our strategic goals as outlined in our strategic plan.
While some of our newest additions are highlighted below, check out all of the other important publications over the last few years under our AAPP papers web page.
 |
With its placement in Psychiatric Services, the American Psychiatric Association’s peer-reviewed journal, this article is designed to educate an interprofessional audience about Board-Certified Psychiatric Pharmacists (BCPPs), their educational training, and their expertise in medication management for people living with psychiatric disorders, including substance use disorders. Along with describing the settings and roles in which BCPPs practice, the article discusses current policies that limit BCPP involvement in behavioral health care and proposed solutions to support the role of BCPPs in addressing behavioral health workforce shortages. |
 |
2024: Role of Board-Certified Psychiatric Pharmacists in child and adolescent psychiatry With a national emergency in child and adolescent psychiatry (CAP), this critical and timely article describes the compelling outcomes being achieved in CAP through interprofessional collaboration among child and adolescent psychiatrists, primary care providers, and BCPPs, among other team members. The article addresses the success of BCPPs in decreasing polypharmacy, increasing medication adherence and knowledge, and enhancing patient outcomes in children and adolescents. |
 |
2023: The mental health workforce needs pharmacists Aligned with ASHP’s Pharmacy Forecast, this commentary details the increasing need for mental health services and the importance of growth in the number of psychiatric pharmacists. The paper details the important and varied roles psychiatric pharmacists play and urges pharmacists to consider the meaningful, rewarding work that can be gained through the provision of team-based care in a high need therapeutic area. It additionally encourages employers to offer mental health services and support the obtainment of the BCPP credential. |
 |
2024: Systematic literature review of the impact of psychiatric pharmacists The Systematic Literature Review Committee of the American Association of Psychiatric Pharmacists was formed and tasked with compiling a comprehensive database of primary literature highlighting the impact of psychiatric pharmacists on patient-level outcomes. With 4270 articles reviewed, this article represents the most extensive and comprehensive evaluation of primary literature to date, highlighting the impact of psychiatric pharmacists on patient-level outcomes. The database underscores the wide range of BCPP clinical practice settings, as well as the varied outcomes used to measure the impact on the quadruple aims of health care. |
 |
2024: Development of the Core Outcome Set for Psychiatric Pharmacists AAPP has developed the Core Outcome Set for Psychiatric Pharmacists (COS-PP) to help define psychiatric pharmacists' support of the interdisciplinary team in addressing the quadruple health care aims. Use of standardized outcomes across practice sites will allow aggregation of data on the impact of psychiatric pharmacists on patient care. Complementing the Core Outcome Set Toolkit, this article details how the Core Outcome Set Committee, following guidelines from the Core Outcome Measures in Effectiveness Trials (COMET) initiative, used literature, a survey of psychiatric pharmacists, and a summit to achieve consensus on the final COS-PP consisting of 21 outcomes grouped according to the quadruple health care aims: better care, reduced health care costs, improved patient experience, and improved clinician well-being. |